Register entry

Shire Human Genetic Therapies, Inc.

Data as of · How to read this entry

Registered sites
4
Active NDC listings
0
Live patents
0
Countries
1
Base
United States
Authorisation

Registered operations

Analytical testing2Active ingredient (API) manufacture2Finished drug manufacture3
Sites

Registered establishments

4
EstablishmentAddressRegistered forFEI / DUNS
Shire Human Genetic Therapies, Inc.33 Brighton Street, Belmont, Massachusetts (MA) 02478, United States (USA)Finished drug manufacture3016455338831834655
Shire Human Genetic Therapies, Inc.205 Alewife Brook Parkway, Cambridge, Massachusetts (MA) 02138, United States (USA)Active ingredient (API) manufacture3005955297831750356
Shire Human Genetic Therapies, Inc.200 Shire Way, Lexington, Massachusetts (MA) 02421, United States (USA)Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture3009340644078478354
Shire Human Genetic Therapies, Inc.200 Riverpark Drive, North Reading, Massachusetts (MA) 01864, United States (USA)Analytical testing, Finished drug manufacture3008424653831834762
Neighbours

Registered in the same town

2
Compare

Comparable companies in United States

Enquiry

Common questions

Is Shire Human Genetic Therapies, Inc. FDA approved?
Shire Human Genetic Therapies, Inc. holds 4 FDA-registered establishments in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Shire Human Genetic Therapies, Inc.'s drugs manufactured?
The FDA register lists Belmont, MA; Cambridge, MA; Lexington, MA; North Reading, MA. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.